UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

The content of aminoacid in blood serum of the patients with Parkinson’s disease

Authors

Type of Article

In the Section

Index UDK:

Abstract

As changes of content of aminoacid and their derivates are one of the reasons of origin of pathological processes, which are related to dysfunctions of the nervous system, the deep study of this link of metabolism at Parkinson’s disease is expedient. It was conducted the determination of content of the complex of aminoacid in blood serum of the patients with Parkinson’s disease with the different degree of severity. The exposed diff erences in the dynamics of changes of levels of neuroactive aminoacid testifi es that at the progressing of Parkinson’s disease there is not only the phenomenon of "XI-toxicity", but it is also marked the forming of the disbalance between the excitant and inhibitor mechanisms with the signs of insuffi ciency of the protective braking, that determines the severity of the disease. Some displays of Parkinson’s disease can be related to the neurotoxic action of excitant neuromediative aminoacid and hypoactivity of inhibitory, and also with the changes of the balance of lysine and homocystein.

Pages

References

  1. Parkinson's disease / [G. N. Kryzhanovsky, I. N. Karaban, S. V. Magayeva et al.]. - Moscow: Medicine, 2002. - 335 с.
  2. Illarioshkin, S. N. Conformation diseases of the brain / S. N. Illarioshkin // M. - Janus-K, 2003. - 248 с.
  3. Wolters, E. Ch. Parkinsonism and Related Disorders / E. Ch. Wolters, T. van Laar, H. W. Berendse. — VU University Press. — Amsterdam, 2008. — 576 p.
  4. Golubev, V. L. Main issues of therapy of late stages of Parkinson's disease / V. L. Golubev // Journal of Neurology and Psychiatry. - 2007. - № 11. - С. 68-76.
  5. Raevsky, K. S. Mediator amino acids: neuropharmacological and neurochemical aspects / K. S. Raevsky, V. P. Georgiev. - Moscow: Medicine, 1986. - 239 с.
  6. Komissarov, I. V. Correction by glutamate receptor ligands of mnestic function disorders in experimental focal cerebral cortex ischemia / I. V. Komissarov, A. V. Zhuravsky, V. E. Gmiro // J. Academy of Medical Sciences of Ukraine. - 2003. - Т. 9. - № 2. - С. 238-250.
  7. Belova, E. I. Fundamentals of neuropharmacology / E. I. Belova // M.: Aspect Press, 2006. - 176 с.
  8. Hyperhomocysteinemia in Parkinson's disease - a new variant of complications of the current therapy or a specific biochemical marker of the disease? / [I. V. Litvinenko, M. M. Odinak, O. S. Sologub et al] // Annals of Clinical and Experimental Neurology. - 2008 - VOL. 2. - NO. 2 - PP. 13-17.
  9. Carmona, F. Purification of GABA on small columns of Dowex 50 W; combination with a method for separation of biogenic amines / F. Carmona, C. Gomes, G. Trolin // Acta pharmacol. et toxicol. — 1980. — Vol. 46. — P. 235—240.
  10. Dambinova, S.A. Neuroreceptors of glutamate / S.A. Dambinova - L.: Nauka, 1989. 143 p.
  11. Gusev E. I., Skvortsova V. I. Cerebral ischemia. М. Medicine, 2001. 328 p.
  12. Kopanitsa, M.V. Extra-synaptic neurotransmitter receptors: distribution, activation mechanisms and physiological role / M.V. Kopanitsa // Neurophysiology. 1997. - Vol. 27. - No. 6. - P. 448-458.
  13. Sircar, R. Glycine reverses 7-chlorokynurenic acid — induced inhibition of [3H] MK-801 binding / R. Sircar, M. J. Frusciante, D. C. Jonth // Brain Res. — 1989. — Vol. 504. — № 2. — P. 325—327.
  14. Brain biochemistry / ed. by I. P. Ashmarin. P. Ashmarin, P. V. Stukalov, N. D. Yeschenko. - SPb.: Izd-vo SPbSU, 1999. - 328 с.
  15. Chalisova, N. I. Modulating role of essential and substituted amino acids in organotypic tissue culture in rats of different age / N. I. Chalisova, V. A., Penniainen // I. M. Sechenov Russian Physiol. Zhurn. - 2003. - Т. 89. - № 5. - С. 591-597.
  16. Dietary L-lysine deficiency increases stressinduced anxiety and fecal excretion in rats / [М. Smriga, М. Kameishi, Н. Uneyama, К. Torii] // J. Nutr. — 2002. — Vol. 132. — № 12. — P. 3744—3746.
  17. P1173L mutation in the methionine synthase gene (MTR) as a cause of hyperhomocysteinemia in ischemic stroke of young age / [I. V. Zorilova, Z. A. Suslina, S. N. Illarioshkin, B. A. Kistenev] // Atmosphere. - Nervous diseases. - 2004. - № 4. - С. 33-35.
  18. Litvinenko, I. V. Parkinson's disease / I. V. Litvinenko. - Moscow: Miklosh, 2006. - 216 с.
  19. Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease / [J. D. Rogers, A. SanchezSaffon, A. B. Frol et al.] // Arch. Neurol. — 2003. — 60. — P. 59—64.